DELL - Pinduoduo Dell Technologies Ulta Beauty among premarket losers' pack
Avadel Pharmaceuticals (AVDL) +39%. Solo Brands (DTC) +14%. PMV Pharmaceuticals (PMVP) +15% on early data for lead asset in solid tumors. Red Robin Gourmet Burgers (RRGB) +13% on Q1 earnings release. DiDi Global (DIDI) +11% on report of China's FAW interest in possible stake. Adicet Bio (ACET) +10% after updating early-stage data for CAR-T therapy in blood cancer. Dell Technologies (DELL) +9% on Q1 earnings release. SIGA Technologies (SIGA) +9%. Molecular Partners (MOLN) +8%. Ulta Beauty (ULTA) +8% on Q1 earnings release. Bright Green (BGXX) +8%. Zymeworks (ZYME) +8% after bidder All Blue Falcons raises state, promising data ahead of ASCO conference. Enservco (ENSV) +7%. Pinduoduo (PDD) +7% on Q1 earnings release. Catalyst Biosciences (CBIO) +6%. PDS Biotechnology (PDSB) +6% after presents data from NCI-Led Triple Combination Phase 2 trial in advanced, refractory HPV-positive cancers at ASCO 2022; and data from VERSATILE-002 Phase 2 trial in recurrent or metastatic head and neck cancer at ASCO 2022. Inovio Pharmaceuticals (INO) +6% after presents results for INO-5401 + INO-9012 in combination with Libtayo
For further details see:
Pinduoduo, Dell Technologies, Ulta Beauty among premarket losers' pack